Show simple item record

dc.contributor.authorTellaloglu, S
dc.contributor.authorZiylan, O
dc.contributor.authorAnder, H
dc.contributor.authorNane, I
dc.contributor.authorKocak, T
dc.contributor.authorEsen, T
dc.date.accessioned2021-03-04T14:17:07Z
dc.date.available2021-03-04T14:17:07Z
dc.date.issued1997
dc.identifier.citationNane I., Ziylan O., Esen T., Kocak T., Ander H., Tellaloglu S., "Primary gonadotropin releasing hormone and adjunctive human chorionic gonadotropin treatment in cryptorchidism: A clinical trial", UROLOGY, cilt.49, sa.1, ss.108-111, 1997
dc.identifier.issn0090-4295
dc.identifier.otherav_80c1369a-d041-4c54-a157-12d1fb074e4d
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/87805
dc.identifier.urihttps://doi.org/10.1016/s0090-4295(96)00359-7
dc.description.abstractObjectives. The effect of intranasal gonadotropin-releasing hormone (GnRH) and intramuscular human chorionic gonadotropin (hCG) in the treatment of cryptorchidism was investigated in 48 prepubertal boys.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectNefroloji
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectÜROLOJİ VE NEFROLOJİ
dc.titlePrimary gonadotropin releasing hormone and adjunctive human chorionic gonadotropin treatment in cryptorchidism: A clinical trial
dc.typeMakale
dc.relation.journalUROLOGY
dc.contributor.department, ,
dc.identifier.volume49
dc.identifier.issue1
dc.identifier.startpage108
dc.identifier.endpage111
dc.contributor.firstauthorID118280


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record